What is a desmoid tumor? A desmoid tumor is a rare fibrous growth that can start in the arms, legs, or torso (body). They most commonly grow in the abdomen (belly). These tumors start in connective ...

SpringWorks to present long-term efficacy and safety data from phase 3 DeFi trial of Ogsiveo in adults with desmoid tumours at CTOS 2024 meeting ...

The results of the DeFi trial of nirogacestat in 142 adults with progressing desmoid tumours showed a significant 71% improvement with the drug on progression-free survival (PFS) compared to ...

An analysis of SpringWorks Therapeutics, Inc., including recent FDA approval, promising sales, and future funding for ...

Two years later, Nansi, from Criccieth in Gwynedd, was diagnosed with desmoid-type fibromatosis (DF), a rare type of soft tissue tumour. "The doctors should have listened to me. I’m her mother ...

Data from the pivotal Phase 2b ReNeu trial demonstrate that patients with NF1-PN achieved deep responses and improvements in ...

Long-term follow-up data highlight further reductions in tumor size, increase in ORR with additional CRs, sustained improvement in desmoid tumor symptoms, and consistent safety profile, now with a med ...

Immunome, Inc. (NASDAQ:IMNM – Get Free Report) has been assigned an average recommendation of “Buy” from the six brokerages ...

To access the live webcast, please visit the Events & Presentations page within the Investors & Media section of the ...

“His expertise will help us advance a portfolio of targeted oncology agents, particularly AL102, a gamma secretase inhibitor currently in a Phase 3 trial for treatment of desmoid tumors.” ...

Immunome, Inc. (the “Company”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapie ...